Private equity-backed site organization roll-up Velocity Clinical Research purchased eStudySite, contributing two trial site locations in San Diego, California to […]
Blackstone has raised more all purpose investment funds than another other private equity group in the United States. With the […]
A new private equity health care fund with an emphasis on life sciences evidences the healthy investor appetite for health […]
Central institutional review board (IRB) consolidator Advarra has acquired another firm—this time a boutique IRB firm called IRBco. This purchase […]
Clinical research site expansion continues at a healthy rate as CenExel Clinical Research, Inc. (“CenExel”) acquires Research Centers of America (RCA), a […]
Private equity giant Blackstone, the world’s third largest private equity investor, continues to move deeper into the life sciences vertical pairing […]
Private equity continues to become more intrigued by clinical trials. From investing in clinical investigational sites to services providers to […]
In yet another private equity-backed consolidation move in the clinical research site market, private equity made a power move again, […]
Medicxi Introduces the €400 Medicxi III fund, closed in just six weeks, and brings the total funds raised in the […]
Genstar Capital, a private equity firm, acquired Advarra from Linden Capital Partners, another private equity house. Advarra offers institutional review board, […]
